Marshall Wace’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$184M Sell
2,636,177
-18,181
-0.7% -$1.01M 0.15% 102
2026
Q1
$113M Buy
2,654,358
+967,143
+57% +$39M 0.11% 144
2025
Q4
$63.2M Buy
1,687,215
+418,935
+33% +$14.1M 0.06% 291
2025
Q3
$37.5M Buy
1,268,280
+935,132
+281% +$21.7M 0.04% 415
2025
Q2
$7.86M Buy
333,148
+155,174
+87% +$3.24M 0.01% 939
2025
Q1
$3.22M Buy
+177,974
New +$3.49M ﹤0.01% 1251
2024
Q2
Sell
-369,224
Closed -$4.01M 3043
2024
Q1
$4.01M Buy
+369,224
New +$3.69M 0.01% 1090

Other funds holding BTSG

Marshall Wace's BTSG Position: Q2 2026 in Review

Marshall Wace reduced its BrightSpring Health Services (BTSG) stake by 0.68% in Q2 2026, selling an estimated $1.01M and leaving 2,636,177 shares worth $184M. The position accounts for 0.15% of the portfolio, ranked #102.

Marshall Wace first reported a position in BTSG in Q1 2024 and has held it in 7 quarters since. 423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

  • Marshall Wace held 2,636,177 shares of BrightSpring Health Services worth $184M as of Q2 2026.
  • Marshall Wace sold 18,181 BrightSpring Health Services shares in Q2 2026, an estimated $1.01M.
  • BrightSpring Health Services made up 0.15% of Marshall Wace's portfolio in Q2 2026, its #102 holding.
  • Marshall Wace first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 7 quarters since.
  • 423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.